PO-2242 HDR-brachytherapy increases PD-L-1 immune expression on prostate cancer (NCT04247217)

Autor: Vanneste, B., Van Limbergen, E., Dubois, L., Wieten, L., Aarts, M., Van Roermund, J., Marcelissen, T., Li, X., Samarasks, I., De Ruysscher, D.
Zdroj: In Radiotherapy and Oncology May 2023 182 Supplement 1:S2017-S2018
Databáze: ScienceDirect